Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche’s HCV Changes Boost Pharmasset Compound

21 Oct 2008

• By Randall Osborne

Lead polymerase inhibitor set aside; R7128 takes center stage.

Related Content

Wyeth Halts Alzheimer’s Trial, Drops HCV Candidate

17 Apr 2008

Idenix Focusing On HIV Program, Tyzeka Launch Following Clinical Hold On Hep C Candidate

13 Jul 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.